Live feed
Filing
SC 13D/A
SC 13D/A0001104659-20-047182·Rein Therapeutics, Inc.
Schedule 13D ownership disclosure
AILERON THERAPEUTICS INC
Security class unavailable · CUSIP: 00887A105
Event date: 2020-04-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,199,904
- Percent of class
- 4.3100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-047182
- Form type
- SC 13D/A
- Filer
- Rein Therapeutics, Inc.
- CIK
- CIK 1420565
- Filed
- Apr 16, 2020
- Reporting period
- Apr 14, 2020
- Description
- Schedule 13D beneficial ownership